Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Similar documents
BNF CHAPTER 11: EYE 1 January 2018

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and

Ophthalmic Special Order Products, General Principles

Ophthalmic Special Order Products, General Principles

Drugs That May Be Used by Certain Optometrists

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT)

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland.

11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.

VI.2.2 Summary of treatment benefits

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection.

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE

Elements for a Public Summary. Overview of disease epidemiology

DQSA Listening Session June 6, 2017

PATIENT CASE HISTORY. General Health Medications Allergies

A Compendium of Product information & Indicative manufacturer s prices

ACETAZOLAMIDE (a-seet-a-zole-a-mide)

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

BNF/BNFC Chapter 11 Eye

Chapter 12 Ear, Nose and Oropharynx

Intravitreal Injection

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5

MECS and Prescribing. Jane Bell BSc FCOptom, DipTpIP, Dip Glauc

Writing a PBS-RPBS prescription authorised optometrists

REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS*

Abbreviated Update: Ophthalmic Glaucoma Agents

Data from the recent therapeutic

Medical Treatment in Pediatric Glaucoma

TA Number. TA Link. Annotation

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

OPHTHALMIC MEDICATIONS

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide.

OPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE

2019 Catalog Hospital and Ophthalmology Products and Services

Chapter 12 Ear, Nose and Oropharynx

Purpose of the Guideline

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Release of the 2013/14 Invitation to Tender

Chronic eye diseases. Title of section divider. What s new, and how GPs can help. Eg. Case Study 1. Dr Jesse Gale, ophthalmologist

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy

12.1 DRUGS ACTING ON THE EAR

Optometrists Formulary. Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London

PHARMACOLOGY FOR OPTOMETRY

Kentucky Department for Medicaid Services. Drug Review Options

The Trust does not record electronically the number of patients who are treated by laser for a condition.

Dry Eye Prescribing Guidelines

Ophthalmological preparations

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

The healthiest place to live and work, by 2025

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Ocular Medication and Compliance

Dry Eye Syndrome Prescribing Guidelines

TA Number. TA Link. Annotation

Pharmaceutical Management Medicaid 2019

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

July Formulary Policy

Summary of the risk management plan (RMP) for Izba (travoprost)

IOP measurements: 8.00 am (trough drug levels) and am (peak drug levels)(2 hours post dose)

Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta369

Get a grip on your glaucoma Booklet 1

PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA

Administration and Supply of Emergency Medicines

Completed Clinical Research Trials Monte Dirks, M.D.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST

Glaucoma: diagnosis and management (large print version)

Optometrists Formulary

10 Musculoskeletal and Joint Diseases

APPLICATION TO INCLUDE A PROCEDURE, PHARMACEUTICAL OR OTHER DATA COLLECTION INSTRUMENT IN THE UNIVERSITY REGISTER

Abbreviated Class Update: Ophthalmics, Glaucoma agents. Month/Year of Review: August 2012 End date of literature search: June 2012

Pharmaceutical quality of reformulated bevacizumab as used in eye conditions in general.

Care homes - Homely remedies

Drug Prescribing Pattern & Adverse Drug Effects Of Anti Glaucoma Medication for Primary Glaucoma at Tertiary Care Hospital

Pharmacology of drugs acting on the eye. Prof. Hanan Hagar Pharmacology Unit College of Medicine

OHTS Baseline/Randomization Visit: BR

Generics are Cheaper and Just as Effective

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Looking after Your Eyesight

concentrate intravenous solution and other strong potassium solutions

Volume 4; Number 6 May 2010

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010

Mild NPDR. Moderate NPDR. Severe NPDR

The use of eye drops and ointments in A&E

Allergies Formulary

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN

LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. No.

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

Summary of Main Points from the Meeting held on Monday 11 th September 2017

Update on management of Anterior Uveitis

National Institute for Health and Clinical Excellence. Glaucoma. Guideline Consultation Comments Table. 29 September November 2008

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy

Transcription:

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing and existing document: Version number: 3.0 S:\Ipswich&East Suffolk CCG\Medicines Management\QIPP workstreams\joint formulary Replacing existing document Approving body: IESCCG Prescribing Workstream Ipswich Hospital Medicines Management Committee (IHT MMC) Date approved: IESCCG Prescribing Workstream: 05/05/15 IHT MMC: 08/05/15 Implementation date: 11/05/15 Author(s): Committee/ group/ individual responsible for updating this document Review date: July 2016 Medicines management pharmacist IESCCG and formulary pharmacist Ipswich Hospital Authors Revision History Version Date Initials Changes marked 1.0 07/2014 CB/RD N/A 2.0 01/2015 CB N/A 2.1 04/2015 CB Yes 3.0 05/2015 CB No Linked Documentation Document title Document file path Primary care formulary S:\Ipswich&East Suffolk CCG\Medicines Management\QIPP workstreams\primary care formulary work Ipswich Hospital Medicines http://www.ipswichhospital.nhs.uk/pharmacy/medicines-formulary.htm Formulary Distribution Who to Via Date Version GP prescribing leads Workshare 01/15 2.0 IHT MMC Meeting 01/15 2.0 IHT formulary pharmacist Email 04/15 2.1

Joint formulary Prescriptions should be written generically unless a specific brand is recommended in the formulary below (will be shown in italics). Excipient intolerances should be included on the prescription If a preservative free eye preparation is required, please specify the rationale in the clinic letter/patient notes. Requests for preservative free products may be questioned if no rationale is provided. NB. The Ipswich Hospital pharmacy will substitute branded prescriptions for generic medication where it is available and more cost effective. Key Italics Most cost effective brand. (OTC) Item available to purchase over the counter from pharmacies and/or supermarkets Bold First choice based on available evidence and cost effectiveness Version: 3.0 Last updated: May 2015 Next review: July 2016 (or sooner if necessary) BNF section Drugs group Formulary Choices Notes 11 Eye Number of per bottle: Bottle size 2.5ml 5ml 10ml Approximate number of contained 50 100 200 If patient has difficulty administering eye, consider co-prescribing an Opticare eye drop dispenser Unlicensed food supplements such as I-Caps etc. for age related macular degeneration should not be prescribed on the NHS. 11.3 Anti-infective eye preparations 11.3.1 Antibacterials Chloramphenicol 0.5% eye (OTC) Chloramphenicol 1% eye ointment (OTC) Fucidic acid 1% gel Ciprofloxacin 0.3% eye Levofloxacin 0.5% eye Available OTC for patients over 2 years old Available OTC for patients over 2 years old Levofloxacin 0.5% preservative. free eye 11.3.3 Antivirals Aciclovir 3% eye ointment 11.4 Corticosteroids and other anti-inflammatory preparations 11.4.1 Corticosteroids Prednisolone 0.5% eye Betamethasone 0.1% eye/ear/nose (Vistamethasone ) Betamethasone 0.1% eye ointment Dexamethasone 0.1% eye (preservative free)

11.4.2 Other antiinflammatory preparations Fluorometholone eye (FML) Dexamethasone 0.1% single use eye (Dropodex ) Maxitrol eye Maxitrol eye ointment Rimexolone 1% eye Loteprenol eye Dexamethasone intravitreal Implant Fluocinolone acetonide intravitreal implant Sodium cromoglicate 2% eye (OTC) Nedocromil 2% eye Olopatadine 1mg/ml eye As per NICE TA229. As per NICE TA301. 11.5 Mydriatics and cycloplegics Antimuscarinics Cyclopentolate 0.5% eye Cyclopentolate 1% eye Cyclopentolate 1% single use Tropicamide 1% single use Tropicamide 0.5% single use Atropine 1% eye Sympathomimetics Phenylephrine 2.5% single use 11.6 Treatment of glaucoma Phenylephrine 10% single use Beta-blockers Timolol 0.25% eye Prostaglandin analogues and prostamides Betaxolol 0.5% eye Timolol 0.1% unit dose eye (Tiopex ) Latanoprost 50mcg/ml eye Latanoprost preservative free eye (Monoprost ) Travoprost 40mcg/ml eye Bimatoprost 100mcg/ml. Reserved for or with poor compliance.. Reserved for.. Bimatoprost 300mcg/ml single. Reserved for use eye. Sympathomimetics Brimonidine 0.2% eye Carbonic anhydrase inhibitors and systemic drugs Dorzolamide 2% eye Brinzolamide 10mg/ml eye Acetazolamide tablets Acetazolamide injection. Reserved for patients intolerant of dorzolamide Hospital only Dorzolamide 2% unit dose eye. Reserved for Miotics Pilocarpine 1% eye Combination preparations Pilocarpine 2% eye Pilocarpine 2% single use Dorzolamide /timolol 2%/0.5% eye Latanoprost /timolol 50mcg/ml/0.5% eye

Brimonidine / Timolol 0.2%/0.5% eye Brinzolamide / timolol 10mg/ml/0.5% eye Bimatoprost / timolol 300mcg/ml/0.5% eye Travoprost /timolol 40mcg/ml/0.5% eye Dorzolamide /timolol 2%/0.5% single use eye 11.7 Local anaesthetics Oxybuprocaine 0.4% single use eye Proxymetacaine 0.5% single use eye Tetracaine 1% single use eye Lidocaine and fluorescein single use eye 11.8 Miscellaneous ophthalmic preparations 11.8.1 Hypromellose 0.3% eye (OTC) Polyvinyl alcohol 1.4% eye (OTC) (Snotears ) Tear deficiency, ocular lubricants, and astringents 11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment Carbomer 980 0.2% (OTC) Liquid paraffin eye ointment (OTC) Carmellose 1% single use eye (OTC) Carmellose 0.5% single use eye (OTC) Sodium chloride 5% preservative free eye / eye ointment [unlicensed special] Acetylcholine intra-ocular irrigation Aflibercept intravitreal injection Apraclonidine 0.5% eye Apraclonidine 1% single use eye Arceole Bevacizumab Injection Brilliant Peel Densiron 68 heavier-than-water endotamponade EasyGas C 2 F 6 pre-mixed syringes EasyGas C 3 F 8 pre-mixed syringes EasyGas SF6 pre-mixed syringes Fluorescein 1% singe use eye. Reserved for Clinitas Carbomer Gel eye is a cost effective brand Xailin Night is a cost effective brand. For night time use. Preservative free Melophthal is a cost effective brand. Each unit of Melophthal is re-sealable and may be used for up to 12 hours. Usual supply one box per month. Preservative free. Xailin Fresh 0.5% is a cost effective brand. Preservative free. As per NICE TA 294, TA305. Hospital use only. Various strengths. Only to be used when other agents not appropriate Off label special available from Moorfields.

Fluorescein 2% single use eye Flurbiprofen 0.03% eye Ketorolac 0.5% eye Ocriplasmin intrvitreal injection Ranibizumab intravitreal injection Vioron* As per NICE TA 297. Hospital only use As per NICE TA155, TA298, TA274, TA283. Joint formulary new drug requests Requests for new drugs from Ipswich Hospital (consultants only) please complete the Ipswich Hospital new drug submission form (available on hospital intranet) Requests for new drugs from primary care please complete the IESCCG new medication request form (available on the IESCCG website) Feedback Please send any feedback or comments to: Ipswich Hospital: Primary care: formulary@ipswichhospital.nhs.uk catherine.butler@ipswichandeastsuffolkccg.nhs.uk